Researchers investigated risk factors for acute COPD exacerbations to guide clinical decision-making for patients with a limited history of COPD. Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are not uncommon in patients...
Researchers investigated risk factors for acute COPD exacerbations to guide clinical decision-making for patients with a limited history of COPD. Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are not uncommon in patients...
The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial,” published in the January 2025 issue of Pulmonology by Ramakrishnan et al. ...
The following is a summary of “Prognostic role of cardiac and inflammatory biomarkers in extubation failure in patients with COVID-19 acute respiratory distress syndrome,” published in the January 2025 issue of Critical Care by Groenland et al. An extubation...
The following is a summary of “Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts,” published in the January 2025 issue of Pulmonology...
The following is a summary of “Ventilation distribution during spontaneous breathing trials predicts liberation from mechanical ventilation: the VISION study,” published in the January 2025 issue of Critical Care by Phoophiboon et al. Predicting successful...
The following is a summary of “Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial,” published in the January 2025 issue of...
The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial,” published in the January 2025 issue of Pulmonology by Ramakrishnan et al. ...
The following is a summary of “Prognostic role of cardiac and inflammatory biomarkers in extubation failure in patients with COVID-19 acute respiratory distress syndrome,” published in the January 2025 issue of Critical Care by Groenland et al. An extubation...
The following is a summary of “Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts,” published in the January 2025 issue of Pulmonology...
The following is a summary of “Ventilation distribution during spontaneous breathing trials predicts liberation from mechanical ventilation: the VISION study,” published in the January 2025 issue of Critical Care by Phoophiboon et al. Predicting successful...
The following is a summary of “Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial,” published in the January 2025 issue of...
A collection of feature articles, study abstracts, and other resources all focused COPD.
The latest news from ASCO 2024 focused on eNSCLC including abstracts, features, and helpful conference information.
Physician’s Weekly-created content featuring key opinion leaders sharing their perspectives on COPD and asthma from different vantage points.
In this medical fiction tale, a goth mortician balances life between the dead and living, exacting dark justice on a predatory funeral home business heir.
Our columnists from ETR discuss the status-neutral approach in HIV, which puts the person—not their HIV status—at the center of prevention and care.
The 2024 holiday season saw a surge in respiratory virus spread, underscoring the ongoing need for holiday-related virus transmission assessment and prevention.
This course discusses why patients with COPD who live in urban areas and in disadvantaged neighborhoods have significantly elevated all-cause mortality, suggesting that social determinants of health may impact COPD outcomes.
A 4-day workweek may reduce physician burnout, lower costs, improve patient care, and boost work-life balance, benefiting healthcare systems overall.
Addressing stressors such as heavy workloads, administrative burdens, and lack of control over work processes can help alleviate physician burnout.
Given the litigious nature of today’s world, physicians must use data-driven insights to both enhance patient safety and reduce malpractice risk.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.